MicroSectors FANG and Innovation 3X Leveraged ETN vs MiniMed Group Inc. Common Stock — how do they compare? MicroSectors FANG and Innovation 3X Leveraged ETN trades at $36.72 (market cap $2.98B), while MiniMed Group Inc. Common Stock trades at $19.66 (market cap $5.57B). The key difference: MiniMed Group Inc. Common Stock is the larger of the two by market cap, and MicroSectors FANG and Innovation 3X Leveraged ETN is trading nearer its 52-week high, MiniMed Group Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MicroSectors FANG and Innovation 3X Leveraged ETN for 19 Days and MiniMed Group Inc. Common Stock for 1 Days on average.
| FNGU | MMED | |
|---|---|---|
Market Cap | $2.98B | $5.57B |
Volume | 4,682,352 | 23,336,073 |
Sector | Leveraged / Inverse | Health |
52-Week High | $37.20 | $23.84 |
52-Week Low | $13.73 | $10.80 |
Typical Hold Time | 19 Days | 1 Days |
Enterprise Value | — | $5.37B |
Signals from Pluang's Aura AI — not financial advice
FNGU, a 3x leveraged ETN tracking major tech stocks, trades at $36.82, down 1.02% today. Technical signals are bullish based on moving averages, with neutral oscillators suggesting potential consolidation. Support and resistance levels are tightly clustered between $33 and $39, indicating a critical price zone. Recent news highlights the ETN's high volatility, having lost 87% during past tech sector downturns, underscoring its leveraged risk profile.
The outlook for FNGU hinges on sustained strength in its underlying tech holdings like Nvidia and Apple. While bullish momentum offers upside potential, the extreme leverage amplifies risks during market corrections. Investors face significant volatility, with losses magnified in downturns, making it suitable only for those with high risk tolerance and short-term horizons.
No Aura AI signal available yet.
Trailing returns across standard periods
FNGU is a leveraged ETN that seeks to provide three times (3x) the daily performance of top tech and innovation stocks. It is intended for traders seeking magnified short-term returns.
Read more on FNGU →MiniMed develops, manufactures, and markets diabetes-management technologies. Its products include insulin-delivery systems, continuous glucose monitors, smart insulin pens, and related software.
Read more on MMED →